CIM vs. PFE
Compare and contrast key facts about Chimera Investment Corporation (CIM) and Pfizer Inc. (PFE).
Performance
CIM vs. PFE - Performance Comparison
Loading graphics...
CIM vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CIM Chimera Investment Corporation | 4.69% | -0.65% | 3.61% | 2.95% | -57.95% | 60.73% | -42.97% | 27.65% | 7.71% | 17.30% |
PFE Pfizer Inc. | 14.66% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
Fundamentals
CIM:
$4.21
PFE:
$1.36
CIM:
2.98
PFE:
20.61
CIM:
0.01
PFE:
0.37
CIM:
2.36
PFE:
2.56
CIM:
$290.86M
PFE:
$62.58B
CIM:
$290.86M
PFE:
$44.01B
CIM:
$331.37M
PFE:
$15.10B
Returns By Period
In the year-to-date period, CIM achieves a 4.69% return, which is significantly lower than PFE's 14.66% return. Over the past 10 years, CIM has underperformed PFE with an annualized return of -0.53%, while PFE has yielded a comparatively higher 4.32% annualized return.
CIM
- 1D
- 2.87%
- 1M
- -4.39%
- YTD
- 4.69%
- 6M
- 1.36%
- 1Y
- 10.29%
- 3Y*
- 1.26%
- 5Y*
- -10.15%
- 10Y*
- -0.53%
PFE
- 1D
- 1.12%
- 1M
- 1.56%
- YTD
- 14.66%
- 6M
- 14.02%
- 1Y
- 18.86%
- 3Y*
- -6.22%
- 5Y*
- -0.14%
- 10Y*
- 4.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CIM vs. PFE — Risk / Return Rank
CIM
PFE
CIM vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Chimera Investment Corporation (CIM) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CIM | PFE | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.33 | 0.71 | -0.38 |
Sortino ratioReturn per unit of downside risk | 0.68 | 1.17 | -0.49 |
Omega ratioGain probability vs. loss probability | 1.09 | 1.15 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | 0.61 | 1.32 | -0.71 |
Martin ratioReturn relative to average drawdown | 1.38 | 3.18 | -1.80 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| CIM | PFE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.33 | 0.71 | -0.38 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.29 | -0.01 | -0.28 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.01 | 0.18 | -0.20 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.06 | 0.26 | -0.32 |
Correlation
The correlation between CIM and PFE is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
CIM vs. PFE - Dividend Comparison
CIM's dividend yield for the trailing twelve months is around 12.43%, more than PFE's 6.13% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CIM Chimera Investment Corporation | 12.43% | 11.91% | 10.14% | 14.03% | 20.36% | 8.55% | 13.66% | 9.73% | 11.22% | 8.12% | 14.34% | 28.15% |
PFE Pfizer Inc. | 6.13% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Drawdowns
CIM vs. PFE - Drawdown Comparison
The maximum CIM drawdown since its inception was -89.69%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for CIM and PFE.
Loading graphics...
Drawdown Indicators
| CIM | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.69% | -58.96% | -30.73% |
Max Drawdown (1Y)Largest decline over 1 year | -18.18% | -12.59% | -5.59% |
Max Drawdown (5Y)Largest decline over 5 years | -69.09% | -58.96% | -10.13% |
Max Drawdown (10Y)Largest decline over 10 years | -72.35% | -58.96% | -13.39% |
Current DrawdownCurrent decline from peak | -61.74% | -42.75% | -18.99% |
Average DrawdownAverage peak-to-trough decline | -51.67% | -17.33% | -34.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.09% | 6.13% | +1.96% |
Volatility
CIM vs. PFE - Volatility Comparison
Chimera Investment Corporation (CIM) has a higher volatility of 7.23% compared to Pfizer Inc. (PFE) at 6.75%. This indicates that CIM's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| CIM | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.23% | 6.75% | +0.48% |
Volatility (6M)Calculated over the trailing 6-month period | 20.83% | 18.50% | +2.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.29% | 26.73% | +4.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 35.27% | 25.46% | +9.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.40% | 23.90% | +12.50% |
Financials
CIM vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Chimera Investment Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities